TO THE TECHNICAL REVIEW ON THE USEFULNESS AND USE OF SECOND-GENERATION ANTIPSYCHOTIC MEDICATIONS.
Table of Contents
IIntroduction and review of issues discussed in national meetings
IICritical review and summary of information about the effects and safety of second-generation antipsychotic medications
Drugs in development
IIIOther developments relevant to the use of second-generation antipsychotic medications
Recent large-scale investigations
Developments concerning regulatory procedures
1.List of Members of the Task Force
2.List of Experts Invited to Comment on the Drafts of the Technical Review
3.List of Organizations Consulted
4.List of National Meetings
5.Partial list of guidelines for the treatment of schizophrenia and related psychotic states, 1991-2001, examined in the preparation of the Technical Review and its Update
6.National Health Service National Institute for Clinical Excellence guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia
7.Resolution adopted by the General Assembly of the World Psychiatric Association on 26 August 2002 in Yokohama, Japan and containing the Consensus Statement on The Usefulness and Use of Second-Generation Antipsychotic Medications.